Dermavant Announces Publication of ADORING 1 & ADORING 2 Pivotal Phase 3 Trials of VTAMA® (tapinarof) cream, 1% for Adults and Children 2 Years of Age and Older with Atopic Dermatitis in JAAD

Dermavant Announces Publication of ADORING 1 & ADORING 2 Pivotal Phase 3 Trials of VTAMA® (tapinarof) cream, 1% for Adults and Children 2 Years of Age and Older with Atopic Dermatitis in JAAD

Business Wire

Published

LONG BEACH, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Dermavant Publishes ADORING 1 & 2 Pivotal Trials of VTAMA® (tapinarof) cream, 1% for Adults and Children with Atopic Dermatitis in JAAD

Full Article